Meridian Bioscience, Inc. (NASDAQ: VIVO):
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
•reported fourth quarter and full-year fiscal 2014 net revenues of $46.7 million and $188.8 million, respectively, a decrease of 5% and an increase of less than 1%, respectively, from the same periods of the prior fiscal year;
Help employers find you! Check out all the jobs and post your resume.
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
•reported fourth quarter and full-year fiscal 2014 net revenues of $46.7 million and $188.8 million, respectively, a decrease of 5% and an increase of less than 1%, respectively, from the same periods of the prior fiscal year;
Help employers find you! Check out all the jobs and post your resume.
